Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. 4 Grant or award Chief Commercial Officer acquired 3,639 shares (grant or award)
  8. 4 Grant or award Pres., R&D, and CMO acquired 5,786 shares (grant or award)
  9. 4 Grant or award Senior VP, Chief Pharma Dev. acquired 1,419 shares (grant or award)
  10. UPLOAD Other SEC-generated Letter
  11. 4 Grant or award Chief Financial Officer acquired 4,803 shares (grant or award)
  12. 4 Grant or award SVP and General Counsel acquired 3,639 shares (grant or award)
  13. 4 Grant or award President and CEO acquired 12,250 shares (grant or award)
  14. SC 13G/A Stake Amended Statement of Ownership
  15. 4 Shares withheld for taxes SVP and General Counsel gave up 949 shares (to pay taxes)
  16. 4 Shares withheld for taxes Director gave up 2,254 shares (to pay taxes)
  17. 4 Shares withheld for taxes Pres., R&D, and CMO gave up 1,546 shares (to pay taxes)
  18. 4 Shares withheld for taxes Senior VP, Chief Pharma Dev. gave up 550 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Financial Officer gave up 1,067 shares (to pay taxes)
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 15 of 62 · 1,224 filings